221 related articles for article (PubMed ID: 36900213)
21. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
22. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y
Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939
[TBL] [Abstract][Full Text] [Related]
24. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
[TBL] [Abstract][Full Text] [Related]
25. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
Liu J; Nie S; Li S; Meng H; Sun R; Yang J; Cheng W
Ann Transl Med; 2020 Jul; 8(14):868. PubMed ID: 32793712
[TBL] [Abstract][Full Text] [Related]
26. SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype.
Wei HF; Zhang RF; Zhao YC; Tong XS
Heliyon; 2023 Sep; 9(9):e20184. PubMed ID: 37809412
[TBL] [Abstract][Full Text] [Related]
27. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma.
Dong Y; Wen W; Yuan T; Liu L; Li X
Am J Transl Res; 2023; 15(2):1072-1084. PubMed ID: 36915776
[TBL] [Abstract][Full Text] [Related]
28. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
29. S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior
Zhao YC; Wang TJ; She LZ; Cui J; Zhang CH
J Cancer; 2023; 14(15):2931-2945. PubMed ID: 37781076
[No Abstract] [Full Text] [Related]
30. Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Xing C; Yin H; Yao ZY; Xing XL
Front Oncol; 2021; 11():774558. PubMed ID: 35087751
[TBL] [Abstract][Full Text] [Related]
31. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
[TBL] [Abstract][Full Text] [Related]
32. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
33. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer.
Zhao YC; Wang TJ; Cui J; She LZ; Zhang RF; Zhang CH
Transl Oncol; 2024 Feb; 40():101839. PubMed ID: 38029507
[TBL] [Abstract][Full Text] [Related]
34. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
[TBL] [Abstract][Full Text] [Related]
35. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Li J; Xi J
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275602
[TBL] [Abstract][Full Text] [Related]
36. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
37. A novel immune-related risk-scoring system associated with the prognosis and response of cervical cancer patients treated with radiation therapy.
Wu Z; Lin Q; Sheng L; Chen W; Liang M; Wu D; Ke Y
Front Mol Biosci; 2023; 10():1297774. PubMed ID: 38028542
[No Abstract] [Full Text] [Related]
38. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
39. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
[TBL] [Abstract][Full Text] [Related]
40. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]